Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing
- PMID: 10854837
- DOI: 10.1016/s0014-2999(00)00318-6
Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing
Abstract
We examined the effects of Delta 9-tetrahydrocannabinol (Delta 9-THC), (R)-(+)-arachidonyl-1'-hydroxy-2'-propylamide ((R)-methanandamide, AM 356), SR 141716, and d-amphetamine on fixed-ratio (FR) responding maintained by food in rats before and during daily dosing with Delta 9-THC. Rats responded under a FR 10 schedule of food reinforcement. Cumulative dose-response curves for the various drugs were determined before and during daily Delta 9-THC administration. All four drugs dose-dependently decreased responding both before and during daily dosing with Delta 9-THC (18 mg/kg/day). The dose-response curves for both Delta 9-THC and (R)-methanandamide were shifted to the right with daily dosing with Delta 9-THC, indicating tolerance to the effects of Delta 9-THC and cross-tolerance to the effects of (R)-methanandamide. The doses of d-amphetamine examined produced similar effects both before and during daily dosing with Delta 9-THC. The effects of SR 141716 were not consistently altered by daily Delta 9-THC administration. These results indicate that tolerance develops to the effects of Delta 9-THC, when Delta 9-THC is administered repeatedly. These results also indicate that cross-tolerance to (R)-methanandamide develops with repeated Delta 9-THC administration.
Similar articles
-
(R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A.Eur J Pharmacol. 2003 Apr 11;466(1-2):121-7. doi: 10.1016/s0014-2999(03)01491-2. Eur J Pharmacol. 2003. PMID: 12679148
-
(R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.Psychopharmacology (Berl). 2001 Aug;156(4):369-80. doi: 10.1007/s002130100730. Psychopharmacology (Berl). 2001. PMID: 11498713
-
Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356).Psychopharmacology (Berl). 2006 Oct;188(3):315-23. doi: 10.1007/s00213-006-0517-x. Epub 2006 Sep 5. Psychopharmacology (Berl). 2006. PMID: 16953384
-
Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.Psychopharmacology (Berl). 2006 Jan;184(1):36-45. doi: 10.1007/s00213-005-0225-y. Epub 2005 Nov 24. Psychopharmacology (Berl). 2006. PMID: 16307294
-
Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.Psychopharmacology (Berl). 2008 Jul;198(4):487-95. doi: 10.1007/s00213-007-0900-2. Epub 2007 Aug 3. Psychopharmacology (Berl). 2008. PMID: 17673980 Free PMC article.
Cited by
-
Operant nociception in nonhuman primates.Pain. 2014 Sep;155(9):1821-1828. doi: 10.1016/j.pain.2014.06.010. Epub 2014 Jun 23. Pain. 2014. PMID: 24968803 Free PMC article.
-
Blood levels do not predict behavioral or physiological effects of Δ⁹-tetrahydrocannabinol in rhesus monkeys with different patterns of exposure.Drug Alcohol Depend. 2014 Jun 1;139:1-8. doi: 10.1016/j.drugalcdep.2014.02.696. Epub 2014 Mar 19. Drug Alcohol Depend. 2014. PMID: 24703610 Free PMC article.
-
Analysis of tolerance and behavioral/physical dependence during chronic CB1 agonist treatment: effects of CB1 agonists, antagonists, and noncannabinoid drugs.J Pharmacol Exp Ther. 2013 Feb;344(2):319-28. doi: 10.1124/jpet.112.198374. Epub 2012 Nov 29. J Pharmacol Exp Ther. 2013. PMID: 23197773 Free PMC article.
-
Tolerance to chronic delta-9-tetrahydrocannabinol (Δ⁹-THC) in rhesus macaques infected with simian immunodeficiency virus.Exp Clin Psychopharmacol. 2011 Apr;19(2):154-72. doi: 10.1037/a0023000. Exp Clin Psychopharmacol. 2011. PMID: 21463073 Free PMC article.
-
Cannabinoid Antagonist Drug Discrimination in Nonhuman Primates.J Pharmacol Exp Ther. 2020 Jan;372(1):119-127. doi: 10.1124/jpet.119.261818. Epub 2019 Oct 22. J Pharmacol Exp Ther. 2020. PMID: 31641018 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials